Inion mulls job cuts to curb spending
This article was originally published in Clinica
Executive Summary
Finnish biodegradable medical implants developer Inion this week said it has embarked on a cost-reduction programme while it tries to obtain more financing. The London Stock Exchange-listed firm has initiated discussions with employees at its Tampere base as part of a "fair consultation" before deciding on whether to make job cuts.